Global Insulin Delivery Devices

Insulin Delivery Devices Comprehensive Study by Type (Syringes, Pens(Reusable Pens Disposable Pens), Jet injectors, Oral insulin, Pumps), Application (Cancer, Diabetes, Chronic Pains, Others), Distribution Channel (Online, Offline), End User (Patients, Homecare, Hospitals, Clinics) Players and Region - Global Market Outlook to 2030

Insulin Delivery Devices Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The devices which are used to inject insulin into the body is called insulin delivery devices, these devices include Syringes, pens, pumps, and jet injectors give many persons with diabetes options for their insulin delivery. According to the research, Diabetes affects 20.9 million people in the U.S. and 347 million people worldwide.1,2 It is estimated that one in three American adults will have diabetes by 2050. Approximately 5% of diabetes cases in the U.S. are classified as type-1 diabetes mellitus, which requires insulin therapy because of β-cell destruction. Of all diabetes cases, 90% to 95% are classified as type-2 diabetes mellitus, which results from a progressive insulin secretory defect against a background of insulin resistance. The demand for the insulin delivery devices conferences meetings and congresses to create awareness about insulin delivery devices. According to AMA Research, the market for Insulin Delivery Devices is expected to register a CAGR of 8.2% during the forecast period to 2030. This growth is primarily driven by Increasing adoption of the Insulin delivery devices as it is the safest and most potent glucose-lowering therapy .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Becton Dickinson and Company (United States), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (United States), Tandem Diabetes Care Inc. (United States), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (United States) and Insulet Corporation (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In August 2020 Medtronic announced its agreement of acquiring Smart Insulin Pen Company Companion Medical. t. The addition of Companion Medical’s InPen to the Medtronic portfolio expands the company’s ability to serve people where they are in their diabetes journey and offer them a unique and expansive ecosystem of support regardless of how insulin is delivered.
In November 2020 Medtronic United States-based company introduced its new integrated smart insulin pen for multiple daily injections. Medtronic's InPen is the only smart insulin pen cleared by the FDA for use by people requiring multiple daily injections. It received that 510(k) back in 2016.The companies are exploring the market by adopting mergers & acquisitions expansions investments new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Influencing Trend:
Technological advancements in insulin delivery devices

Market Growth Drivers:
Increasing adoption of the Insulin delivery devices as it is the safest and most potent glucose-lowering therapy and Conferences meetings and congresses to create awareness about insulin delivery devices

Challenges:
Concern Associated With the Reuse of Pen Needles and Infusion Sets

Restraints:
Use of Alternative Drug Delivery Method

Opportunities:
Growing diabetic population and Increasing diabetes-related health expenditure in emerging economies

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Insulin Delivery Devices Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Insulin Delivery Devices Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Insulin Delivery Devices players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Insulin Delivery Devices Study Sheds Light on
— The Insulin Delivery Devices Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Insulin Delivery Devices industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Insulin Delivery Devices industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Syringes
  • Pens(Reusable Pens Disposable Pens)
  • Jet injectors
  • Oral insulin
  • Pumps
By Application
  • Cancer
  • Diabetes
  • Chronic Pains
  • Others
By Distribution Channel
  • Online
  • Offline

By End User
  • Patients
  • Homecare
  • Hospitals
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing adoption of the Insulin delivery devices as it is the safest and most potent glucose-lowering therapy
      • 3.2.2. Conferences meetings and congresses to create awareness about insulin delivery devices
    • 3.3. Market Challenges
      • 3.3.1. Concern Associated With the Reuse of Pen Needles and Infusion Sets
    • 3.4. Market Trends
      • 3.4.1. Technological advancements in insulin delivery devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Insulin Delivery Devices, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Insulin Delivery Devices (Value)
      • 5.2.1. Global Insulin Delivery Devices by: Type (Value)
        • 5.2.1.1. Syringes
        • 5.2.1.2. Pens(Reusable Pens Disposable Pens)
        • 5.2.1.3. Jet injectors
        • 5.2.1.4. Oral insulin
        • 5.2.1.5. Pumps
      • 5.2.2. Global Insulin Delivery Devices by: Application (Value)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Chronic Pains
        • 5.2.2.4. Others
      • 5.2.3. Global Insulin Delivery Devices by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Insulin Delivery Devices by: End User (Value)
        • 5.2.4.1. Patients
        • 5.2.4.2. Homecare
        • 5.2.4.3. Hospitals
        • 5.2.4.4. Clinics
      • 5.2.5. Global Insulin Delivery Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Insulin Delivery Devices (Volume)
      • 5.3.1. Global Insulin Delivery Devices by: Type (Volume)
        • 5.3.1.1. Syringes
        • 5.3.1.2. Pens(Reusable Pens Disposable Pens)
        • 5.3.1.3. Jet injectors
        • 5.3.1.4. Oral insulin
        • 5.3.1.5. Pumps
      • 5.3.2. Global Insulin Delivery Devices by: Application (Volume)
        • 5.3.2.1. Cancer
        • 5.3.2.2. Diabetes
        • 5.3.2.3. Chronic Pains
        • 5.3.2.4. Others
      • 5.3.3. Global Insulin Delivery Devices by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Insulin Delivery Devices by: End User (Volume)
        • 5.3.4.1. Patients
        • 5.3.4.2. Homecare
        • 5.3.4.3. Hospitals
        • 5.3.4.4. Clinics
      • 5.3.5. Global Insulin Delivery Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Insulin Delivery Devices (Price)
      • 5.4.1. Global Insulin Delivery Devices by: Type (Price)
  • 6. Insulin Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novo Nordisk A/S (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ypsomed Holding AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic plc (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Animas Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Tandem Diabetes Care Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biocon Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Insulet Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Insulin Delivery Devices Sale, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Insulin Delivery Devices (Value)
      • 7.2.1. Global Insulin Delivery Devices by: Type (Value)
        • 7.2.1.1. Syringes
        • 7.2.1.2. Pens(Reusable Pens Disposable Pens)
        • 7.2.1.3. Jet injectors
        • 7.2.1.4. Oral insulin
        • 7.2.1.5. Pumps
      • 7.2.2. Global Insulin Delivery Devices by: Application (Value)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Chronic Pains
        • 7.2.2.4. Others
      • 7.2.3. Global Insulin Delivery Devices by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Insulin Delivery Devices by: End User (Value)
        • 7.2.4.1. Patients
        • 7.2.4.2. Homecare
        • 7.2.4.3. Hospitals
        • 7.2.4.4. Clinics
      • 7.2.5. Global Insulin Delivery Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Insulin Delivery Devices (Volume)
      • 7.3.1. Global Insulin Delivery Devices by: Type (Volume)
        • 7.3.1.1. Syringes
        • 7.3.1.2. Pens(Reusable Pens Disposable Pens)
        • 7.3.1.3. Jet injectors
        • 7.3.1.4. Oral insulin
        • 7.3.1.5. Pumps
      • 7.3.2. Global Insulin Delivery Devices by: Application (Volume)
        • 7.3.2.1. Cancer
        • 7.3.2.2. Diabetes
        • 7.3.2.3. Chronic Pains
        • 7.3.2.4. Others
      • 7.3.3. Global Insulin Delivery Devices by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Insulin Delivery Devices by: End User (Volume)
        • 7.3.4.1. Patients
        • 7.3.4.2. Homecare
        • 7.3.4.3. Hospitals
        • 7.3.4.4. Clinics
      • 7.3.5. Global Insulin Delivery Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Insulin Delivery Devices (Price)
      • 7.4.1. Global Insulin Delivery Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Insulin Delivery Devices: by Type(USD Million)
  • Table 2. Insulin Delivery Devices Syringes , by Region USD Million (2018-2023)
  • Table 3. Insulin Delivery Devices Pens(Reusable Pens Disposable Pens) , by Region USD Million (2018-2023)
  • Table 4. Insulin Delivery Devices Jet injectors , by Region USD Million (2018-2023)
  • Table 5. Insulin Delivery Devices Oral insulin , by Region USD Million (2018-2023)
  • Table 6. Insulin Delivery Devices Pumps , by Region USD Million (2018-2023)
  • Table 7. Insulin Delivery Devices: by Application(USD Million)
  • Table 8. Insulin Delivery Devices Cancer , by Region USD Million (2018-2023)
  • Table 9. Insulin Delivery Devices Diabetes , by Region USD Million (2018-2023)
  • Table 10. Insulin Delivery Devices Chronic Pains , by Region USD Million (2018-2023)
  • Table 11. Insulin Delivery Devices Others , by Region USD Million (2018-2023)
  • Table 12. Insulin Delivery Devices: by Distribution Channel(USD Million)
  • Table 13. Insulin Delivery Devices Online , by Region USD Million (2018-2023)
  • Table 14. Insulin Delivery Devices Offline , by Region USD Million (2018-2023)
  • Table 15. Insulin Delivery Devices: by End User(USD Million)
  • Table 16. Insulin Delivery Devices Patients , by Region USD Million (2018-2023)
  • Table 17. Insulin Delivery Devices Homecare , by Region USD Million (2018-2023)
  • Table 18. Insulin Delivery Devices Hospitals , by Region USD Million (2018-2023)
  • Table 19. Insulin Delivery Devices Clinics , by Region USD Million (2018-2023)
  • Table 20. South America Insulin Delivery Devices, by Country USD Million (2018-2023)
  • Table 21. South America Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 22. South America Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 23. South America Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 24. South America Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 25. Brazil Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 26. Brazil Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 27. Brazil Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 28. Brazil Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 29. Argentina Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 30. Argentina Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 31. Argentina Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 32. Argentina Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 33. Rest of South America Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 36. Rest of South America Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 37. Asia Pacific Insulin Delivery Devices, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 41. Asia Pacific Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 42. China Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 43. China Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 44. China Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 45. China Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 46. Japan Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 47. Japan Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 48. Japan Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 49. Japan Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 50. India Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 51. India Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 52. India Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 53. India Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 54. South Korea Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 55. South Korea Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 56. South Korea Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 57. South Korea Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 58. Taiwan Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 59. Taiwan Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 60. Taiwan Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 61. Taiwan Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 62. Australia Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 63. Australia Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 64. Australia Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 65. Australia Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 70. Europe Insulin Delivery Devices, by Country USD Million (2018-2023)
  • Table 71. Europe Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 72. Europe Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 73. Europe Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 74. Europe Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 75. Germany Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 76. Germany Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 77. Germany Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 78. Germany Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 79. France Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 80. France Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 81. France Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 82. France Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 83. Italy Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 84. Italy Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 85. Italy Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 86. Italy Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 87. United Kingdom Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 88. United Kingdom Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 90. United Kingdom Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 91. Netherlands Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 92. Netherlands Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 93. Netherlands Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 94. Netherlands Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 95. Rest of Europe Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 98. Rest of Europe Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 99. MEA Insulin Delivery Devices, by Country USD Million (2018-2023)
  • Table 100. MEA Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 101. MEA Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 102. MEA Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 103. MEA Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 104. Middle East Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 105. Middle East Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 106. Middle East Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 107. Middle East Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 108. Africa Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 109. Africa Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 110. Africa Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 111. Africa Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 112. North America Insulin Delivery Devices, by Country USD Million (2018-2023)
  • Table 113. North America Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 114. North America Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 115. North America Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 116. North America Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 117. United States Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 118. United States Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 119. United States Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 120. United States Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 121. Canada Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 122. Canada Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 123. Canada Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 124. Canada Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 125. Mexico Insulin Delivery Devices, by Type USD Million (2018-2023)
  • Table 126. Mexico Insulin Delivery Devices, by Application USD Million (2018-2023)
  • Table 127. Mexico Insulin Delivery Devices, by Distribution Channel USD Million (2018-2023)
  • Table 128. Mexico Insulin Delivery Devices, by End User USD Million (2018-2023)
  • Table 129. Insulin Delivery Devices Sales: by Type(K Units)
  • Table 130. Insulin Delivery Devices Sales Syringes , by Region K Units (2018-2023)
  • Table 131. Insulin Delivery Devices Sales Pens(Reusable Pens Disposable Pens) , by Region K Units (2018-2023)
  • Table 132. Insulin Delivery Devices Sales Jet injectors , by Region K Units (2018-2023)
  • Table 133. Insulin Delivery Devices Sales Oral insulin , by Region K Units (2018-2023)
  • Table 134. Insulin Delivery Devices Sales Pumps , by Region K Units (2018-2023)
  • Table 135. Insulin Delivery Devices Sales: by Application(K Units)
  • Table 136. Insulin Delivery Devices Sales Cancer , by Region K Units (2018-2023)
  • Table 137. Insulin Delivery Devices Sales Diabetes , by Region K Units (2018-2023)
  • Table 138. Insulin Delivery Devices Sales Chronic Pains , by Region K Units (2018-2023)
  • Table 139. Insulin Delivery Devices Sales Others , by Region K Units (2018-2023)
  • Table 140. Insulin Delivery Devices Sales: by Distribution Channel(K Units)
  • Table 141. Insulin Delivery Devices Sales Online , by Region K Units (2018-2023)
  • Table 142. Insulin Delivery Devices Sales Offline , by Region K Units (2018-2023)
  • Table 143. Insulin Delivery Devices Sales: by End User(K Units)
  • Table 144. Insulin Delivery Devices Sales Patients , by Region K Units (2018-2023)
  • Table 145. Insulin Delivery Devices Sales Homecare , by Region K Units (2018-2023)
  • Table 146. Insulin Delivery Devices Sales Hospitals , by Region K Units (2018-2023)
  • Table 147. Insulin Delivery Devices Sales Clinics , by Region K Units (2018-2023)
  • Table 148. South America Insulin Delivery Devices Sales, by Country K Units (2018-2023)
  • Table 149. South America Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 150. South America Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 151. South America Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 152. South America Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 153. Brazil Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 154. Brazil Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 155. Brazil Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 156. Brazil Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 157. Argentina Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 158. Argentina Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 159. Argentina Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 160. Argentina Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 161. Rest of South America Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 162. Rest of South America Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 163. Rest of South America Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 164. Rest of South America Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 165. Asia Pacific Insulin Delivery Devices Sales, by Country K Units (2018-2023)
  • Table 166. Asia Pacific Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 167. Asia Pacific Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 168. Asia Pacific Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 169. Asia Pacific Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 170. China Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 171. China Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 172. China Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 173. China Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 174. Japan Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 175. Japan Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 176. Japan Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 177. Japan Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 178. India Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 179. India Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 180. India Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 181. India Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 182. South Korea Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 183. South Korea Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 184. South Korea Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 185. South Korea Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 186. Taiwan Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 187. Taiwan Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 188. Taiwan Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 189. Taiwan Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 190. Australia Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 191. Australia Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 192. Australia Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 193. Australia Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 194. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 195. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 196. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 197. Rest of Asia-Pacific Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 198. Europe Insulin Delivery Devices Sales, by Country K Units (2018-2023)
  • Table 199. Europe Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 200. Europe Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 201. Europe Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 202. Europe Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 203. Germany Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 204. Germany Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 205. Germany Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 206. Germany Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 207. France Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 208. France Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 209. France Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 210. France Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 211. Italy Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 212. Italy Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 213. Italy Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 214. Italy Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 215. United Kingdom Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 216. United Kingdom Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 217. United Kingdom Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 218. United Kingdom Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 219. Netherlands Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 220. Netherlands Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 221. Netherlands Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 222. Netherlands Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 223. Rest of Europe Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 224. Rest of Europe Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 225. Rest of Europe Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 226. Rest of Europe Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 227. MEA Insulin Delivery Devices Sales, by Country K Units (2018-2023)
  • Table 228. MEA Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 229. MEA Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 230. MEA Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 231. MEA Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 232. Middle East Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 233. Middle East Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 234. Middle East Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 235. Middle East Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 236. Africa Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 237. Africa Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 238. Africa Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 239. Africa Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 240. North America Insulin Delivery Devices Sales, by Country K Units (2018-2023)
  • Table 241. North America Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 242. North America Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 243. North America Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 244. North America Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 245. United States Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 246. United States Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 247. United States Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 248. United States Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 249. Canada Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 250. Canada Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 251. Canada Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 252. Canada Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 253. Mexico Insulin Delivery Devices Sales, by Type K Units (2018-2023)
  • Table 254. Mexico Insulin Delivery Devices Sales, by Application K Units (2018-2023)
  • Table 255. Mexico Insulin Delivery Devices Sales, by Distribution Channel K Units (2018-2023)
  • Table 256. Mexico Insulin Delivery Devices Sales, by End User K Units (2018-2023)
  • Table 257. Insulin Delivery Devices: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Insulin Delivery Devices: by Type(USD Million)
  • Table 269. Insulin Delivery Devices Syringes , by Region USD Million (2025-2030)
  • Table 270. Insulin Delivery Devices Pens(Reusable Pens Disposable Pens) , by Region USD Million (2025-2030)
  • Table 271. Insulin Delivery Devices Jet injectors , by Region USD Million (2025-2030)
  • Table 272. Insulin Delivery Devices Oral insulin , by Region USD Million (2025-2030)
  • Table 273. Insulin Delivery Devices Pumps , by Region USD Million (2025-2030)
  • Table 274. Insulin Delivery Devices: by Application(USD Million)
  • Table 275. Insulin Delivery Devices Cancer , by Region USD Million (2025-2030)
  • Table 276. Insulin Delivery Devices Diabetes , by Region USD Million (2025-2030)
  • Table 277. Insulin Delivery Devices Chronic Pains , by Region USD Million (2025-2030)
  • Table 278. Insulin Delivery Devices Others , by Region USD Million (2025-2030)
  • Table 279. Insulin Delivery Devices: by Distribution Channel(USD Million)
  • Table 280. Insulin Delivery Devices Online , by Region USD Million (2025-2030)
  • Table 281. Insulin Delivery Devices Offline , by Region USD Million (2025-2030)
  • Table 282. Insulin Delivery Devices: by End User(USD Million)
  • Table 283. Insulin Delivery Devices Patients , by Region USD Million (2025-2030)
  • Table 284. Insulin Delivery Devices Homecare , by Region USD Million (2025-2030)
  • Table 285. Insulin Delivery Devices Hospitals , by Region USD Million (2025-2030)
  • Table 286. Insulin Delivery Devices Clinics , by Region USD Million (2025-2030)
  • Table 287. South America Insulin Delivery Devices, by Country USD Million (2025-2030)
  • Table 288. South America Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 289. South America Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 290. South America Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 291. South America Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 292. Brazil Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 293. Brazil Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 294. Brazil Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 295. Brazil Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 296. Argentina Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 297. Argentina Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 298. Argentina Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 299. Argentina Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 300. Rest of South America Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 301. Rest of South America Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 302. Rest of South America Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 303. Rest of South America Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 304. Asia Pacific Insulin Delivery Devices, by Country USD Million (2025-2030)
  • Table 305. Asia Pacific Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 306. Asia Pacific Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 307. Asia Pacific Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 308. Asia Pacific Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 309. China Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 310. China Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 311. China Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 312. China Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 313. Japan Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 314. Japan Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 315. Japan Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 316. Japan Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 317. India Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 318. India Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 319. India Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 320. India Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 321. South Korea Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 322. South Korea Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 323. South Korea Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 324. South Korea Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 325. Taiwan Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 326. Taiwan Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 327. Taiwan Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 328. Taiwan Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 329. Australia Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 330. Australia Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 331. Australia Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 332. Australia Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 333. Rest of Asia-Pacific Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 334. Rest of Asia-Pacific Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 335. Rest of Asia-Pacific Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 336. Rest of Asia-Pacific Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 337. Europe Insulin Delivery Devices, by Country USD Million (2025-2030)
  • Table 338. Europe Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 339. Europe Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 340. Europe Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 341. Europe Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 342. Germany Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 343. Germany Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 344. Germany Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 345. Germany Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 346. France Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 347. France Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 348. France Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 349. France Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 350. Italy Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 351. Italy Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 352. Italy Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 353. Italy Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 354. United Kingdom Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 355. United Kingdom Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 356. United Kingdom Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 357. United Kingdom Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 358. Netherlands Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 359. Netherlands Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 360. Netherlands Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 361. Netherlands Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 362. Rest of Europe Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 363. Rest of Europe Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 364. Rest of Europe Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 365. Rest of Europe Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 366. MEA Insulin Delivery Devices, by Country USD Million (2025-2030)
  • Table 367. MEA Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 368. MEA Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 369. MEA Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 370. MEA Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 371. Middle East Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 372. Middle East Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 373. Middle East Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 374. Middle East Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 375. Africa Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 376. Africa Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 377. Africa Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 378. Africa Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 379. North America Insulin Delivery Devices, by Country USD Million (2025-2030)
  • Table 380. North America Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 381. North America Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 382. North America Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 383. North America Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 384. United States Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 385. United States Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 386. United States Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 387. United States Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 388. Canada Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 389. Canada Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 390. Canada Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 391. Canada Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 392. Mexico Insulin Delivery Devices, by Type USD Million (2025-2030)
  • Table 393. Mexico Insulin Delivery Devices, by Application USD Million (2025-2030)
  • Table 394. Mexico Insulin Delivery Devices, by Distribution Channel USD Million (2025-2030)
  • Table 395. Mexico Insulin Delivery Devices, by End User USD Million (2025-2030)
  • Table 396. Insulin Delivery Devices Sales: by Type(K Units)
  • Table 397. Insulin Delivery Devices Sales Syringes , by Region K Units (2025-2030)
  • Table 398. Insulin Delivery Devices Sales Pens(Reusable Pens Disposable Pens) , by Region K Units (2025-2030)
  • Table 399. Insulin Delivery Devices Sales Jet injectors , by Region K Units (2025-2030)
  • Table 400. Insulin Delivery Devices Sales Oral insulin , by Region K Units (2025-2030)
  • Table 401. Insulin Delivery Devices Sales Pumps , by Region K Units (2025-2030)
  • Table 402. Insulin Delivery Devices Sales: by Application(K Units)
  • Table 403. Insulin Delivery Devices Sales Cancer , by Region K Units (2025-2030)
  • Table 404. Insulin Delivery Devices Sales Diabetes , by Region K Units (2025-2030)
  • Table 405. Insulin Delivery Devices Sales Chronic Pains , by Region K Units (2025-2030)
  • Table 406. Insulin Delivery Devices Sales Others , by Region K Units (2025-2030)
  • Table 407. Insulin Delivery Devices Sales: by Distribution Channel(K Units)
  • Table 408. Insulin Delivery Devices Sales Online , by Region K Units (2025-2030)
  • Table 409. Insulin Delivery Devices Sales Offline , by Region K Units (2025-2030)
  • Table 410. Insulin Delivery Devices Sales: by End User(K Units)
  • Table 411. Insulin Delivery Devices Sales Patients , by Region K Units (2025-2030)
  • Table 412. Insulin Delivery Devices Sales Homecare , by Region K Units (2025-2030)
  • Table 413. Insulin Delivery Devices Sales Hospitals , by Region K Units (2025-2030)
  • Table 414. Insulin Delivery Devices Sales Clinics , by Region K Units (2025-2030)
  • Table 415. South America Insulin Delivery Devices Sales, by Country K Units (2025-2030)
  • Table 416. South America Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 417. South America Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 418. South America Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 419. South America Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 420. Brazil Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 421. Brazil Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 422. Brazil Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 423. Brazil Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 424. Argentina Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 425. Argentina Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 426. Argentina Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 427. Argentina Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 428. Rest of South America Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 429. Rest of South America Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 430. Rest of South America Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 431. Rest of South America Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 432. Asia Pacific Insulin Delivery Devices Sales, by Country K Units (2025-2030)
  • Table 433. Asia Pacific Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 434. Asia Pacific Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 435. Asia Pacific Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 436. Asia Pacific Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 437. China Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 438. China Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 439. China Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 440. China Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 441. Japan Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 442. Japan Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 443. Japan Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 444. Japan Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 445. India Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 446. India Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 447. India Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 448. India Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 449. South Korea Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 450. South Korea Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 451. South Korea Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 452. South Korea Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 453. Taiwan Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 454. Taiwan Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 455. Taiwan Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 456. Taiwan Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 457. Australia Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 458. Australia Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 459. Australia Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 460. Australia Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 461. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 462. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 463. Rest of Asia-Pacific Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 464. Rest of Asia-Pacific Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 465. Europe Insulin Delivery Devices Sales, by Country K Units (2025-2030)
  • Table 466. Europe Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 467. Europe Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 468. Europe Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 469. Europe Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 470. Germany Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 471. Germany Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 472. Germany Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 473. Germany Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 474. France Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 475. France Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 476. France Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 477. France Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 478. Italy Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 479. Italy Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 480. Italy Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 481. Italy Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 482. United Kingdom Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 483. United Kingdom Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 484. United Kingdom Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 485. United Kingdom Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 486. Netherlands Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 487. Netherlands Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 488. Netherlands Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 489. Netherlands Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 490. Rest of Europe Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 491. Rest of Europe Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 492. Rest of Europe Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 493. Rest of Europe Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 494. MEA Insulin Delivery Devices Sales, by Country K Units (2025-2030)
  • Table 495. MEA Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 496. MEA Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 497. MEA Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 498. MEA Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 499. Middle East Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 500. Middle East Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 501. Middle East Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 502. Middle East Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 503. Africa Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 504. Africa Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 505. Africa Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 506. Africa Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 507. North America Insulin Delivery Devices Sales, by Country K Units (2025-2030)
  • Table 508. North America Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 509. North America Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 510. North America Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 511. North America Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 512. United States Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 513. United States Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 514. United States Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 515. United States Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 516. Canada Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 517. Canada Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 518. Canada Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 519. Canada Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 520. Mexico Insulin Delivery Devices Sales, by Type K Units (2025-2030)
  • Table 521. Mexico Insulin Delivery Devices Sales, by Application K Units (2025-2030)
  • Table 522. Mexico Insulin Delivery Devices Sales, by Distribution Channel K Units (2025-2030)
  • Table 523. Mexico Insulin Delivery Devices Sales, by End User K Units (2025-2030)
  • Table 524. Insulin Delivery Devices: by Type(USD/Units)
  • Table 525. Research Programs/Design for This Report
  • Table 526. Key Data Information from Secondary Sources
  • Table 527. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Delivery Devices: by Type USD Million (2018-2023)
  • Figure 5. Global Insulin Delivery Devices: by Application USD Million (2018-2023)
  • Figure 6. Global Insulin Delivery Devices: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Insulin Delivery Devices: by End User USD Million (2018-2023)
  • Figure 8. South America Insulin Delivery Devices Share (%), by Country
  • Figure 9. Asia Pacific Insulin Delivery Devices Share (%), by Country
  • Figure 10. Europe Insulin Delivery Devices Share (%), by Country
  • Figure 11. MEA Insulin Delivery Devices Share (%), by Country
  • Figure 12. North America Insulin Delivery Devices Share (%), by Country
  • Figure 13. Global Insulin Delivery Devices: by Type K Units (2018-2023)
  • Figure 14. Global Insulin Delivery Devices: by Application K Units (2018-2023)
  • Figure 15. Global Insulin Delivery Devices: by Distribution Channel K Units (2018-2023)
  • Figure 16. Global Insulin Delivery Devices: by End User K Units (2018-2023)
  • Figure 17. South America Insulin Delivery Devices Share (%), by Country
  • Figure 18. Asia Pacific Insulin Delivery Devices Share (%), by Country
  • Figure 19. Europe Insulin Delivery Devices Share (%), by Country
  • Figure 20. MEA Insulin Delivery Devices Share (%), by Country
  • Figure 21. North America Insulin Delivery Devices Share (%), by Country
  • Figure 22. Global Insulin Delivery Devices: by Type USD/Units (2018-2023)
  • Figure 23. Global Insulin Delivery Devices share by Players 2023 (%)
  • Figure 24. Global Insulin Delivery Devices share by Players (Top 3) 2023(%)
  • Figure 25. Global Insulin Delivery Devices share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 29. Novo Nordisk A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 30. Novo Nordisk A/S (Denmark) Revenue: by Geography 2023
  • Figure 31. Ypsomed Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Ypsomed Holding AG (Switzerland) Revenue: by Geography 2023
  • Figure 33. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 35. Animas Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Animas Corporation (United States) Revenue: by Geography 2023
  • Figure 37. Tandem Diabetes Care Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Tandem Diabetes Care Inc. (United States) Revenue: by Geography 2023
  • Figure 39. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 40. Sanofi (France) Revenue: by Geography 2023
  • Figure 41. Biocon Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 42. Biocon Ltd. (India) Revenue: by Geography 2023
  • Figure 43. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 44. Eli Lilly and Company (United States) Revenue: by Geography 2023
  • Figure 45. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 46. Insulet Corporation (United States) Revenue: by Geography 2023
  • Figure 47. Global Insulin Delivery Devices: by Type USD Million (2025-2030)
  • Figure 48. Global Insulin Delivery Devices: by Application USD Million (2025-2030)
  • Figure 49. Global Insulin Delivery Devices: by Distribution Channel USD Million (2025-2030)
  • Figure 50. Global Insulin Delivery Devices: by End User USD Million (2025-2030)
  • Figure 51. South America Insulin Delivery Devices Share (%), by Country
  • Figure 52. Asia Pacific Insulin Delivery Devices Share (%), by Country
  • Figure 53. Europe Insulin Delivery Devices Share (%), by Country
  • Figure 54. MEA Insulin Delivery Devices Share (%), by Country
  • Figure 55. North America Insulin Delivery Devices Share (%), by Country
  • Figure 56. Global Insulin Delivery Devices: by Type K Units (2025-2030)
  • Figure 57. Global Insulin Delivery Devices: by Application K Units (2025-2030)
  • Figure 58. Global Insulin Delivery Devices: by Distribution Channel K Units (2025-2030)
  • Figure 59. Global Insulin Delivery Devices: by End User K Units (2025-2030)
  • Figure 60. South America Insulin Delivery Devices Share (%), by Country
  • Figure 61. Asia Pacific Insulin Delivery Devices Share (%), by Country
  • Figure 62. Europe Insulin Delivery Devices Share (%), by Country
  • Figure 63. MEA Insulin Delivery Devices Share (%), by Country
  • Figure 64. North America Insulin Delivery Devices Share (%), by Country
  • Figure 65. Global Insulin Delivery Devices: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Becton Dickinson and Company (United States)
  • Novo Nordisk A/S (Denmark)
  • Ypsomed Holding AG (Switzerland)
  • Medtronic plc (Ireland)
  • Animas Corporation (United States)
  • Tandem Diabetes Care Inc. (United States)
  • Sanofi (France)
  • Biocon Ltd. (India)
  • Eli Lilly and Company (United States)
  • Insulet Corporation (United States)
Additional players considered in the study are as follows:
Abbott Laboratories (United States) , Ascensia Diabetes Care Holdings AG (Switzerland) , Hoffmann-La Roche Ltd.( Switzerland)
Select User Access Type

Key Highlights of Report


Mar 2024 206 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Insulin Delivery Devices Quantitative research analysis
Global Insulin Delivery Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Insulin Delivery Devices Market are Becton Dickinson and Company (United States), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (United States), Tandem Diabetes Care Inc. (United States), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (United States) and Insulet Corporation (United States) etc.
Cancer segment in Global market to hold robust market share owing to "Increasing adoption of the Insulin delivery devices as it is the safest and most potent glucose-lowering therapy ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Insulin Delivery Devices market throughout the forecasted period.

Know More About Global Insulin Delivery Devices Report?

Have a Query? Click Here

Other Related Reports

CBD Oil Comprehensive Study by Type (Marijuana-Derived CBD Oil Products, Hemp-Derived CBD Oil Products), Application (Medical, Recreational), Distribution Channel (Hospital Pharmacies, Retail Pharmac...
$ 3650
Contraceptives Comprehensive Study by Type (Oral Contraceptive Pills, Contraceptive Injectable, Topical Contraceptive Patch), Application (Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory...
$ 3650
Encephalitis Vaccine Comprehensive Study by Application (Child, Adult), End User (Hospitals, Clinics, Vaccination Centers, Others), Strain (Nakayama, Beijing, P-3, SA 14-14-2) Players and Region - Gl...
$ 3500
Medical Marijuana Comprehensive Study by Type (Buds, Oil, Tinctures), Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Marijuana Type (Medical Marijuana, Recreational...
$ 3500
Orphan Drugs Comprehensive Study by Drug Type (Biologics, Non-Biologics), Sale (Generics, Prescribed), Drugs (Revlimid, Rituxan, Opdivo, Others), Disease Type (Oncology, Gastrointestinal, Pulmonary, ...
$ 3750
Diptheria Vaccine Comprehensive Study by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), Disease Type (Diphtheria, Tetanus, Pertussis), Packaging Type (0.5 ML, 1 ML, 2 ML, Others), A...
$ 3450